The KO-MED Clinical Centers Zamość facility was officially opened in November 2013 and has been actively operating since early 2014. In 2024, the facility became part of the Velocity Clinical Research structure. The center conducts Phase II-IV clinical trials across a wide range of indications, such as cardiology, rheumatology, urology, internal medicine, diabetology, and vaccines. The entire staff and collaborating researchers have many years of experience in clinical research, ensuring high-quality patient care. Through its activities, the center has established collaborations with local hospitals and general practitioners’ offices, enabling Velocity Zamość to support recruitment in various indications.
Now Enroling in Zamość
Velocity is enroling participants for clinical trials in Zamość for the following conditions:
- Atrial Fibrillation (AFib)
- Flu Vaccine
- Heart Failure
- Hypertriglyceridemia (High Triglycerides)
- Myocardial Infaction with Type 2 Diabetes
- Stroke with Type 2 Diabetes
- Type 2 Diabetes